Dominik F Vollherbst1,2, Ruth Otto1, Thuy Do2, Hans U Kauczor2, Martin Bendszus1, Christof M Sommer2,3, Markus A Möhlenbruch1. 1. 1 Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany. 2. 2 Clinic for Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany. 3. 3 Clinic for Diagnostic and Interventional Radiology, Klinikum Stuttgart, Stuttgart, Germany.
Abstract
BACKGROUND AND PURPOSE: A frequently reported drawback of ethylene vinyl alcohol copolymer-based liquid embolic agents is the production of artifacts in diagnostic imaging. New embolic agents, such as Precipitating hydrophobic injectable liquid (PHIL; MicroVention, Tustin, CA, USA), are supposed to induce significantly fewer artifacts. The purpose of this study is to assess the degree of artifacts induced by the liquid embolic agents Onyx (Medtronic Neurovascular, Irvine, CA, USA) and PHIL in conventional computed tomography (CT), cone-beam CT and magnetic resonance imaging (MRI) in an experimental in vivo model. MATERIALS AND METHODS: In 10 pigs the rete mirabile was embolized with Onyx ( n = 5) or PHIL ( n = 5). After embolization, conventional CT, cone-beam CT and MRI were performed. The degree of artifacts was graded qualitatively (five-point scale; for CT and MRI) and quantitatively (HUs of well-defined regions of interest (ROIs); for CT only). RESULTS: Artifacts were significantly more severe for Onyx both in the qualitative (e.g. conventional CT: 2 versus 5 (medians); p = 0.008) and in the quantitative image analysis (e.g. cone-beam CT: standard deviation of a ROI near to the embolic agent cast, 94 HU versus 38 HU (medians); p = 0.008). Neither Onyx nor PHIL produced any apparent artifacts in MRI. CONCLUSION: PHIL produces fewer artifacts than Onyx in conventional CT and cone-beam CT in an experimental in vivo model.
BACKGROUND AND PURPOSE: A frequently reported drawback of ethylene vinyl alcohol copolymer-based liquid embolic agents is the production of artifacts in diagnostic imaging. New embolic agents, such as Precipitating hydrophobic injectable liquid (PHIL; MicroVention, Tustin, CA, USA), are supposed to induce significantly fewer artifacts. The purpose of this study is to assess the degree of artifacts induced by the liquid embolic agents Onyx (Medtronic Neurovascular, Irvine, CA, USA) and PHIL in conventional computed tomography (CT), cone-beam CT and magnetic resonance imaging (MRI) in an experimental in vivo model. MATERIALS AND METHODS: In 10 pigs the rete mirabile was embolized with Onyx ( n = 5) or PHIL ( n = 5). After embolization, conventional CT, cone-beam CT and MRI were performed. The degree of artifacts was graded qualitatively (five-point scale; for CT and MRI) and quantitatively (HUs of well-defined regions of interest (ROIs); for CT only). RESULTS: Artifacts were significantly more severe for Onyx both in the qualitative (e.g. conventional CT: 2 versus 5 (medians); p = 0.008) and in the quantitative image analysis (e.g. cone-beam CT: standard deviation of a ROI near to the embolic agent cast, 94 HU versus 38 HU (medians); p = 0.008). Neither Onyx nor PHIL produced any apparent artifacts in MRI. CONCLUSION: PHIL produces fewer artifacts than Onyx in conventional CT and cone-beam CT in an experimental in vivo model.
Authors: L Pierot; C Cognard; D Herbreteau; H Fransen; W J van Rooij; E Boccardi; A Beltramello; N Sourour; K Kupcs; A Biondi; A Bonafé; W Reith; A Casasco Journal: Eur Radiol Date: 2013-05-08 Impact factor: 5.315
Authors: Dominik Vollherbst; Robert C Bertheau; Stefan Fritz; Carolin Mogler; Hans-Ulrich Kauczor; Eduard Ryschich; Boris A Radeleff; Philippe L Pereira; Christof M Sommer Journal: J Vasc Interv Radiol Date: 2016-04-18 Impact factor: 3.464
Authors: Christof M Sommer; Markus A Möhlenbruch; Dominik F Vollherbst; Ruth Otto; Andreas von Deimling; Johannes Pfaff; Christian Ulfert; Hans U Kauczor; Martin Bendszus Journal: J Neurointerv Surg Date: 2017-07-08 Impact factor: 5.836
Authors: David N Loy; Keith M Rich; Joseph Simpson; Ian Dorward; Lakshmi Santanam; Colin P Derdeyn Journal: Neurosurg Focus Date: 2009-05 Impact factor: 4.047
Authors: N Schmitt; R O Floca; D Paech; R A El Shafie; F Seker; M Bendszus; M A Möhlenbruch; D F Vollherbst Journal: AJNR Am J Neuroradiol Date: 2020-11-19 Impact factor: 3.825
Authors: Isabelle Riederer; Daniel Bar-Ness; Melanie A Kimm; Salim Si-Mohamed; Peter B Noël; Ernst J Rummeny; Philippe Douek; Daniela Pfeiffer Journal: Sci Rep Date: 2019-03-27 Impact factor: 4.379
Authors: Niclas Schmitt; Charlotte S Weyland; Lena Wucherpfennig; Christof M Sommer; Martin Bendszus; Markus A Möhlenbruch; Dominik F Vollherbst Journal: J Neurointerv Surg Date: 2021-08-25 Impact factor: 8.572
Authors: Niclas Schmitt; Charlotte S Weyland; Lena Wucherpfennig; Christian Herweh; Martin Bendszus; Markus A Möhlenbruch; Dominik F Vollherbst Journal: Clin Neuroradiol Date: 2021-10-13 Impact factor: 3.156
Authors: Niclas Schmitt; Ralf O Floca; Daniel Paech; Rami A El Shafie; Ulf Neuberger; Martin Bendszus; Markus A Möhlenbruch; Dominik F Vollherbst Journal: Clin Neuroradiol Date: 2021-04-14 Impact factor: 3.649